Aaron G.l. Fletcher, Director at Cue Biopharma, Inc. (CUE), bought 205,000 shares at $3.52 ($712K) on 2022-05-23, disclosed to the SEC on 2022-05-25.
Open-market purchase of $712k CUE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.52 | 150,000 | $528K | 74.2% |
| 2 | $3.34 | 55,000 | $184K | 25.8% |
| Total | $3.47 avg | 205,000 | $712K | 100% |
| Filing → |
| TFFP | BUY | 2022-11-23 | $50K | — | Filing → |
| TFFP | BUY | 2022-05-17 | $538K | — | Filing → |
| TFFP | BUY | 2022-04-04 | $3.5M | — | Filing → |